Scarica l'app Stockscreener
21.60
3.03%
-0.65
Dopo l'orario di chiusura:
21.58
-0.02
-0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$22.25
Aprire:
$22.36
Volume 24 ore:
195.03K
Relative Volume:
0.56
Capitalizzazione di mercato:
$1.04B
Reddito:
$151.91M
Utile/perdita netta:
$-46.03M
Rapporto P/E:
-21.39
EPS:
-1.01
Flusso di cassa netto:
$5.65M
1 W Prestazione:
-2.02%
1M Prestazione:
-10.25%
6M Prestazione:
-10.33%
1 anno Prestazione:
-18.09%
Intervallo 1D:
$21.45
$22.36
Intervallo di 1 settimana:
$21.35
$22.99
Portata 52W:
$19.10
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
21.60 | 1.07B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
478.34 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.83 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.54 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.59 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
245.84 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
BioLife Solutions, Inc. Signs Multi-Year Supply Agreement with Qkine Limited to Expand Its Product Portfolio into the Rapidly Growing Cytokines Market - marketscreener.com
BioLife Solutions (BLFS) Secures Supply Deal with Qkine for Key CGT Products - GuruFocus
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - PR Newswire
Aug Big Picture: What are analysts price targets for BioLife Solutions Inc2025 Biggest Moves & Weekly Return Optimization Plans - baoquankhu1.vn
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica - GlobeNewswire Inc.
Energy Moves: Is BioLife Solutions Inc being accumulated by smart moneyIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn
Options Flow: Does BioLife Solutions Inc offer margin of safetyMarket Sentiment Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors - DirectorsTalk Interviews
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions - Yahoo Finance
H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock - MSN
Weekly Recap: Whats the profit margin of BioLife Solutions IncJuly 2025 Retail & Fast Gain Stock Trading Tips - baoquankhu1.vn
Movement Recap: Should I invest in BioLife Solutions Inc before earningsWeekly Market Outlook & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is BioLife Solutions Inc a cyclical or defensive stockQuarterly Investment Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Buyout Rumor: What is the PEG ratio of BioLife Solutions IncJuly 2025 Rallies & Weekly High Momentum Picks - baoquankhu1.vn
BioLife Solutions Inc (BLFS) Stock Price Down 4.32% on Jan 28 - GuruFocus
BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Bank Watch: How does NewAmsterdam Pharma Company NV Equity Warrant compare to its peersQuarterly Market Review & Daily Growth Stock Tips - baoquankhu1.vn
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load? - 富途资讯
(BLFS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
BioLife Solutions, Inc. (BLFS): Investor Outlook With A 32.86% Potential Upside - DirectorsTalk Interviews
Energy Moves: What is the PEG ratio of BioLife Solutions IncTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Is Global Indemnity Group LLC stock undervalued right nowEarnings Miss & Daily Market Momentum Tracking - baoquankhu1.vn
Contrasting BioLife Solutions (NASDAQ:BLFS) and Phibro Animal Health (NASDAQ:PAHC) - Defense World
Stronger Q4 Revenue and Leadership Change Might Change The Case For Investing In BioLife Solutions (BLFS) - simplywall.st
Should you avoid BioLife Solutions Inc. stock right now2025 Winners & Losers & Reliable Breakout Stock Forecasts - bollywoodhelpline.com
Aug Patterns: What margin trends mean for BioLife Solutions Inc stockBuy Signal & Daily Oversold Bounce Ideas - Bộ Nội Vụ
BioLife Solutions reports 20% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Rate Hike: Is BioLife Solutions Inc being accumulated by smart moneyJuly 2025 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
BioLife Solutions reports 20% revenue growth in Q4 2025 - Investing.com
Biolife Solutions Announces Preliminary Fourth Quarter And Full Year 2025 Unaudited Revenue From Continuing Operations - TradingView
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations - PR Newswire
Summit Creek Advisors LLC Makes New Investment in BioLife Solutions, Inc. $BLFS - MarketBeat
Insider Sell: Should you avoid BioLife Solutions Inc stock right nowQuarterly Earnings Report & Daily Technical Forecast Reports - baoquankhu1.vn
BioLife Solutions announces planned retirement of key executive - TipRanks
Will BioLife Solutions Inc. stock gain from government policiesQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - Улправда
Is BioLife Solutions Inc. stock affected by interest rate hikesWeekly Trade Report & Daily Price Action Insights - Улправда
Why BioLife Solutions Inc. stock could benefit from AI revolution2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - Улправда
Foster, chief quality at BioLife, sells $8572 in shares By Investing.com - Investing.com Nigeria
Troy Wichterman, Biolife Solutions CFO, sells $25k in shares By Investing.com - Investing.com Nigeria
Aebersold, Biolife Solutions CHRO, sells $6k in shares By Investing.com - Investing.com Canada
Troy Wichterman, Biolife Solutions CFO, sells $25k in shares - Investing.com
Aby J. Mathew, Biolife Solutions evp, sells $10k in shares - Investing.com India
Aby J. Mathew, Biolife Solutions evp, sells $10k in shares By Investing.com - Investing.com South Africa
Biolife Solutions CMO Berard sells $8.8k in shares By Investing.com - Investing.com South Africa
Biolife Solutions CMO Berard sells $8.8k in shares - Investing.com India
Insider Selling: BioLife Solutions (NASDAQ:BLFS) CFO Sells 990 Shares of Stock - MarketBeat
Is BioLife Solutions Inc. (BJX1) stock a defensive play amid uncertaintyEarnings Risk Summary & Target Return Focused Stock Picks - ulpravda.ru
Why analysts upgrade BioLife Solutions Inc. stockJuly 2025 Final Week & Accurate Entry/Exit Alerts - ulpravda.ru
What is Northland Capmk’s Forecast for BLFS Q1 Earnings? - Defense World
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $34 - 富途牛牛
BioLife Solutions, Inc. (BLFS) Stock Analysis: 28% Upside Potential and Strong Revenue Growth - DirectorsTalk Interviews
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biolife Solutions Inc Azioni (BLFS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Foster Karen A. | Chief Quality and Operations |
Jan 06 '26 |
Sale |
25.59 |
335 |
8,573 |
191,984 |
| Aebersold Sarah | Chief Human Resources Officer |
Jan 06 '26 |
Sale |
25.59 |
241 |
6,167 |
75,765 |
| Mathew Aby J. | EVP & Chief Scientific Officer |
Jan 06 '26 |
Sale |
25.59 |
405 |
10,364 |
349,350 |
| Berard Todd | Chief Marketing Officer |
Jan 06 '26 |
Sale |
25.59 |
344 |
8,803 |
132,564 |
| Mathew Aby J. | EVP & Chief Scientific Officer |
Dec 09 '25 |
Sale |
25.13 |
631 |
15,857 |
349,755 |
| Wichterman Troy | Chief Financial Officer |
Dec 09 '25 |
Sale |
25.13 |
1,033 |
25,959 |
151,736 |
| Aebersold Sarah | Chief Human Resources Officer |
Dec 15 '25 |
Sale |
24.46 |
713 |
17,440 |
76,006 |
| Aebersold Sarah | Chief Human Resources Officer |
Dec 09 '25 |
Sale |
25.13 |
233 |
5,855 |
76,719 |
| DuRoss Amy | Director |
Dec 15 '25 |
Sale |
24.60 |
2,000 |
49,200 |
18,687 |
| Berard Todd | Chief Marketing Officer |
Dec 09 '25 |
Sale |
25.13 |
358 |
8,997 |
132,908 |
6.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):